Kare Schultz
Director · Hims & Hers Health, Inc.
- 2025
- Aug 18, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kare Schultz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Dudum - $11.03M in HIMS purchases and sales in the last 12 months
- Oluyemi Okupe - $9.22M in HIMS purchases and sales in the last 12 months
- Michael Chi - $3.24M in HIMS purchases and sales in the last 12 months
- Soleil Boughton - $1.87M in HIMS purchases and sales in the last 12 months
- David B. Wells - $1.17M in HIMS purchases and sales in the last 12 months
- Mohamed Elshenawy - $1.17M in HIMS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kare Schultz?
Kare Schultz is a corporate insider, tracked as Director of Hims & Hers Health, Inc. (HIMS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kare Schultz submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.